UB30:LSE:LSE-UBS MSCI Emerging Markets UCITS (USD)

ETF | Others |

Last Closing

USD 108.045

Change

-0.61 (-0.56)%

Market Cap

N/A

Volume

942.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-2.81 (-1.03%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+5.50 (+2.66%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-1.11 (-0.74%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.11 (-0.78%)

USD 584.80B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.17 (-0.98%)

USD 583.82B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.30 (-0.47%)

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.21 (-0.70%)

USD 218.91B
0QZ3:LSE Qualcomm Inc.

-3.51 (-2.13%)

USD 202.26B

ETFs Containing UB30:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.26% 51% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.26% 51% F 53% F
Trailing 12 Months  
Capital Gain 9.92% 49% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.92% 50% F 52% F
Trailing 5 Years  
Capital Gain 2.04% 33% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.04% 33% F 44% F
Average Annual (5 Year Horizon)  
Capital Gain 2.70% 36% F 45% F
Dividend Return 3.87% 42% F 49% F
Total Return 1.17% 67% D+ 78% C+
Risk Return Profile  
Volatility (Standard Deviation) 20.74% 32% F 48% F
Risk Adjusted Return 18.65% 37% F 50% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.